Engineering prostate cancer in vitro: what does it take?

A key challenge in the clinical management and cause of treatment failure of prostate cancer (PCa) is its molecular, cellular and clinical heterogeneity. Modelling systems that fully recapitulate clinical diversity and resistant phenotypes are urgently required for the development of successful pers...

Descripción completa

Detalles Bibliográficos
Autores principales: Buskin, Adriana, Scott, Emma, Nelson, Ryan, Gaughan, Luke, Robson, Craig N., Heer, Rakesh, Hepburn, Anastasia C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403358/
https://www.ncbi.nlm.nih.gov/pubmed/37438470
http://dx.doi.org/10.1038/s41388-023-02776-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403358/
https://www.ncbi.nlm.nih.gov/pubmed/37438470
http://dx.doi.org/10.1038/s41388-023-02776-6

Ejemplares similares